Loading organizations...
Loading organizations...
Neuroscience-focused company developing treatments for depression.
Euthymics Bioscience has raised $28.0M across 2 funding rounds.
Euthymics Bioscience has raised $28.0M in total across 2 funding rounds.
Euthymics Bioscience has raised $28.0M in total across 2 funding rounds.
Euthymics Bioscience's investors include Novartis, Venture Investors, Tim Barberich, GBS Venture Partners, H&Q Healthcare Investors, H&Q Life Sciences Investors, Campbell Murray, Paul Weiss, Andrew Baker, Frank Gentile, State of Wisconsin Investment Board.
Euthymics Bioscience has raised $28.0M across 2 funding rounds. Most recently, it raised $4.0M Series A Extension in March 2011.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 9, 2011 | $4.0M Series A Extension | Novartis, Venture Investors | Tim Barberich, GBS Venture Partners, H&Q Healthcare Investors, H&Q Life Sciences Investors |
| Jul 22, 2010 | $24.0M Series A | Campbell Murray, Paul Weiss | Andrew Baker, Frank Gentile, State of Wisconsin Investment Board |